| Kenalog Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Kenalog 0.1% | ointment | topical | 100.0 gram(s) | OTC |
| Kenalog 0.147 mg/g | spray | topical | 1.0 gram(s) | OTC |
| Kenalog 0.1% | lotion | topical | 100.0 milliliter(s) | OTC |
| Kenalog 0.025% | lotion | topical | 100.0 milliliter(s) | OTC |
| Kenalog 0.1% | cream | topical | 100.0 gram(s) | OTC |
| Kenalog 0.025% | cream | topical | 100.0 gram(s) | OTC |
| Kenalog 0.5% | cream | topical | 100.0 gram(s) | OTC |
Posted by cyhadd 1 day ago
I am freaking out reading all of this. My dermatologist just injected my scalp about 20 times with Kenalog for female pattern...
Posted by thom12 4 days ago
Had the shot on Monday the 19the of October for allergies, went on brisk walk on Tues evening had tightening of chest numbing...
Posted by amygeorge512 11 days ago
Both my husband and my son have had Kenalog Injections for Hay Fever for quite a few years. I heard recently that long term u...
Endophthalmitis rates low in ongoing intravitreal steroid trials - OSN SuperSite (subscription)
In pooled data from seven other studies involving 3248 patients treated with intravitreal injections of Kenalog (triamcinolone, Bristol-Meyers Squibb), ...
Fri Jan 25 14:12:43 -0500 2008
Advice: Dr. Donohue - NorthJersey.com
He sent me to an ear, nose and throat doctor, who said the white patches look like lichen planus, and he has me on Kenalog in Orabase. ...
Fri Dec 14 09:56:01 -0500 2007
The FDA Raises Safety Concerns Regarding Off-Label Use of Avastin ... - StreetInsider.com (subscription)
... Therapeutics Drugs Mentioned: - Aflibercept (VEGF Trap) - Avastin (bevacizumab) - Herceptin (trastuzumab) - Kenalog/Kenacort (triamcinolone acetonide, ...
Wed Jan 02 13:37:48 -0500 2008
triamcinolone acetonide - The acetonide salt form of triamcinolone, a synthetic glucocorticosteroid with immunosuppressive and anti-inflammatory activity. Triamcinolone acetonide binds to specific cytosolic glucocorticoid receptors and subsequently interacts with glucocorticoid receptor response element on DNA and alters gene expression. This results in an induction of the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are accomplished.